Optimizing Value through Appropriate Use of Invasive Cardiovascular Services
The perceived role of invasive cardiac services, especially percutaneous transluminal interventions (PCI), has changed significantly over the past 5-10 years. New healthcare payment models will apply new pressures to assure that only procedures of high value are performed. I will review changes in the use of, and perceptions about, invasive cardiac services over the past several decades, and explore how new models of care management may help optimize use of these expensive but useful services.
Dr. Garratt joined Christiana Health System as Associate Director, Center for Heart and Vascular Health in 2015. He also serves as Director, CV Quality and Safety, and as Director, CV Research. He is highly engaged in the Society for Cardiac Angiography and Intervention (SCAI), a national society with a focus on quality of invasive CV care, participating in numerous activities including Quality, Steering and Executive Committees.
The Innovative Discoveries Series, sponsored by the Delaware Clinical & Translational Science ACCEL program and the Christiana Care Value Institute, features informal presentations on topics relevant to current research and healthcare practice, led by knowledgeable and experienced presenters. There are offerings for researchers, healthcare providers, and community members of varying levels of experience.
These free talks are held Fridays at noon at Christiana Hospital but can be viewed from your home or office computer. Earn CMEs by participating in-person or online. Lunch is served and all are welcome to attend.
To see the full calendar of events, visit the Value Institute Events page or the ACCEL website, or subscribe to the ID Series mailing list.
Contact Sarahfaye Dolman at sarahfaye.f.dolman@christianacare.org with any questions.